Loading...
XKRX
024720
Market cap189mUSD
Jul 10, Last price  
8,390.00KRW
1D
0.72%
1Q
-6.88%
Jan 2017
-75.10%
IPO
155.64%
Name

Kolmar Korea Holdings Co Ltd

Chart & Performance

D1W1MN
XKRX:024720 chart
P/E
12.28
P/S
0.46
EPS
683.32
Div Yield, %
3.00%
Shrs. gr., 5y
13.10%
Rev. gr., 5y
-1.38%
Revenues
630.11b
-6.88%
85,262,922,000125,587,928,000153,543,293,000188,064,645,000270,992,597,000324,517,641,240106,625,624,260132,262,221,010222,474,428,770299,567,094,920330,438,588,910490,565,263,210561,696,121,310593,433,802,000675,480,246,000674,006,002,000649,879,569,000637,274,323,000676,663,182,000630,111,809,000
Net income
23.44b
-4.61%
8,259,696,0005,779,183,0005,578,004,00011,736,504,00011,228,895,00018,708,505,00019,763,903,7508,766,407,52019,513,981,870-742,369,50036,641,942,55028,032,100,06090,232,664,18072,236,251,000113,135,323,00021,816,148,000-6,086,492,000-3,715,524,00024,568,325,00023,435,195,000
CFO
31.03b
-21.46%
4,554,246,0006,176,510,00011,829,878,00011,746,555,00012,932,321,00015,609,991,90018,257,937,15013,425,256,63029,219,839,92026,535,547,42025,257,525,88068,303,392,34038,455,787,30084,102,125,00083,326,143,00015,327,486,000-11,348,010,00043,903,567,00039,504,064,00031,026,275,000
Dividend
Aug 13, 202550 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kolmar Korea Holdings Co., Ltd. is engaged in the manufacturing and global distribution of cosmetics, pharmaceutical products, and nutritional supplements, serving markets both within South Korea and internationally. Its comprehensive range of beauty offerings includes skincare, makeup, haircare, body care, and products designed for infants, alongside specialized functional cosmetics and fragrances. Furthermore, the company provides over-the-counter medications and dietary aids. Founded in 1990, its main corporate headquarters are situated in Sejong City, South Korea.
URL
http://www.kolmar.co.kr
IPO date
Apr 09, 2002
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT